G Agnese
Biographic Data
| ID | 7864753 |
|---|---|
| NAME | G Agnese |
| GIVEN NAMES | G |
| FAMILY NAME | Agnese |
| SIGNATURE | AGNESE G |
| AFFILIATIONS | Federico II University Hospital |
| ORCID | 0000-0003-4002-0930 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from Covid-19
The use of corticosteroids for COVID-19 respiratory impairment seems to be the most common risk factor for PJP, together with viral-induced and iatrogenic lymphopenia. The worsening in respiratory function and the characteristic radiological picture during or after COVID-19 pneumonia should raise the suspicion of PJP, even in immunocompetent patients. PJP primary chemoprophylaxis can be considered in selected high-risk COVID-19 patients, but furt…
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with Covid-19 Pneumonia
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolme…
No prominent works on this page.
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from Covid-19
The use of corticosteroids for COVID-19 respiratory impairment seems to be the most common risk factor for PJP, together with viral-induced and iatrogenic lymphopenia. The worsening in respiratory function and the characteristic radiological picture during or after COVID-19 pneumonia should raise the suspicion of PJP, even in immunocompetent patients. PJP primary chemoprophylaxis can be considered in selected high-risk COVID-19 patients, but furt…
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with Covid-19 Pneumonia
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolme…
Coronavirus disease 2019 (COVID-19 (2 works) · Disease (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pneumonia (2 works) · Atypical pneumonia (1 work) · Chemoprophylaxis (1 work) · Dermatological and COVID-19 studies (1 work) · Drug-Induced Adverse Reactions (1 work) · Gastroenterology (1 work)